Patents by Inventor Yasuko Kawamata

Yasuko Kawamata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091185
    Abstract: Compositions, containing glycine and serine and having a content ratio of glycine to serine (glycine/serine) of not less than 0.6 in weight ratio are effective for improving cognitive function, and have an effective preventive or improving effect on a decline in cognitive function and cognitive dysfunction, are highly safe, and enable continuous ingestion or administration.
    Type: Application
    Filed: November 20, 2023
    Publication date: March 21, 2024
    Applicant: AJINOMOTO CO., INC.
    Inventors: Hidehiro NAKAMURA, Noriko KAWASAKI, Yasuko KAWAMATA, Akihiko KITAMURA, Ryosei SAKAI, Fumika TAKEUCHI
  • Patent number: 7388030
    Abstract: The present invention provides a method for suppressing hemolytic anemia by selectively ameliorating reticulocyte increase and iron deposition on spleen caused as the side effects of methionine. The present invention also provides an appetite suppressor with reduced such side effects, where threonine is used as the effective ingredient of the suppressor of hemolytic anemia due to methionine and a combination of methionine and threonine is used as the effective ingredient of the appetite suppressor.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: June 17, 2008
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yasuko Kawamata, Takeshi Kimura, Makoto Miura, Sakino Toue, Ryousei Sakai
  • Publication number: 20040214894
    Abstract: The present invention provides a method for suppressing hemolytic anemia by selectively ameliorating reticulocyte increase and iron deposition on spleen caused as the side effects of methionine. The present invention also provides an appetite suppressor with reduced such side effects, where threonine is used as the effective ingredient of the suppressor of hemolytic anemia due to methionine and a combination of methionine and threonine is used as the effective ingredient of the appetite suppressor.
    Type: Application
    Filed: May 24, 2004
    Publication date: October 28, 2004
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yasuko Kawamata, Takeshi Kimura, Makoto Miura, Sakino Toue, Ryousei Sakai
  • Publication number: 20030018075
    Abstract: The present invention provides a method for suppressing hemolytic anemia by selectively ameliorating reticulocyte increase and iron deposition on spleen caused as the side effects of methionine. The present invention also provides an appetite suppressor with reduced such side effects, where threonine is used as the effective ingredient of the suppressor of hemolytic anemia due to methionine and a combination of methionine and threonine is used as the effective ingredient of the appetite suppressor.
    Type: Application
    Filed: May 31, 2002
    Publication date: January 23, 2003
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yasuko Kawamata, Takeshi Kimura, Makoto Miura, Sakino Toue, Ryousei Sakai